Category: finance
-

SEBI Approves Phased Restructuring of Nifty Bank and Financial Indices by March 2026
SEBI Announces Phased Restructuring of Major Indian Banking Indices October 30, 2025 – India’s markets regulator, Securities and Exchange Board of India (SEBI), announced a phased restructuring of key banking and financial indices, including: The move affects indices linked to derivatives contracts, aiming to improve broad-based representation and reduce vulnerability to market manipulation. Timeline for
-

Global Stocks Dip as Megacaps Weigh; Yen Weakens After BOJ Announcement
Megacaps Drag Global Markets Lower October 30, 2025 – Global shares declined sharply, marking their largest daily drop in three weeks, as megacap tech stocks Microsoft and Meta Platforms experienced significant losses. On Wall Street, Meta plunged nearly 12% after releasing quarterly results Wednesday, coupled with reports of a planned $25 billion bond sale. Microsoft
-

Yen Weakens as Bank of Japan Holds Rates Steady; Fed Comments Strengthen U.S. Dollar
Yen Drops as BOJ Holds Rates and Fed Tone Lifts Dollar October 30, 2025 – The Japanese yen weakened sharply against the U.S. dollar on Thursday after the Bank of Japan (BOJ) left interest rates unchanged and struck a less hawkish tone than markets expected. Meanwhile, the U.S. dollar rose, supported by remarks from Federal
-

Kellanova Q3 Earnings Beat Estimates on Strong Demand for Breakfast Staples
Kellanova Surpasses Wall Street Estimates October 30, 2025 – Kellanova (NYSE: K.N) reported stronger-than-expected third-quarter sales and profits on Thursday, fueled by resilient demand for ready-to-eat breakfast items and snacks, including Pringles and Pop-Tarts. The company posted net sales of $3.26 billion, slightly above analysts’ forecasts of $3.25 billion. Adjusted earnings came in at $0.94
-

Merck Posts Strong Q3 Revenue as Keytruda Growth Offsets Gardasil Decline
Merck’s Q3 Revenue Climbs on Keytruda Immunotherapy October 30, 2025 – Merck & Co. (NYSE: MRK) reported higher third-quarter revenue, powered by continued growth from its blockbuster cancer immunotherapy Keytruda, which offset declining sales of the human papillomavirus (HPV) vaccine Gardasil, particularly in China. The company posted $17.28 billion in revenue, surpassing analyst expectations of
-

CK Hutchison and Iliad Explore Italian Telecom Tie-Up: Potential Market Shake-Up
CK Hutchison and Iliad Hold Talks on Italian Telecom Merger October 30, 2025 – Hong Kong-based conglomerate CK Hutchison Holdings (0001.HK) is exploring a potential tie-up of its Italian telecom unit Wind Tre with the Italian operations of French telecom group Iliad, according to sources familiar with the matter. The discussions are at an early
-

C.H. Robinson Shares Soar to Record High Amid Freight Industry Slump Thanks to AI Innovation
C.H. Robinson Defies Freight Industry Headwinds with AI-Powered Gains October 30, 2025 – Shares of C.H. Robinson (NASDAQ: CHRW) surged more than 20% on Thursday, reaching an all-time high as investors celebrated the company’s quarterly profit beat, driven largely by AI-enhanced operational efficiency. The performance is particularly noteworthy given the broader challenges facing the freight
-

Sterling Stabilizes After Multi-Month Lows Ahead of Bank of England Meeting
Sterling steadied on Thursday against the U.S. dollar and euro after two days of sharp depreciation, though volatility is expected to continue ahead of next week’s Bank of England (BoE) monetary policy meeting. The pound was last trading at $1.3182, slightly above Wednesday’s intraday low of $1.3142, marking its weakest level against the dollar in
-

Japan’s Finance Minister Satsuki Katayama Distances Herself from Past Yen Comments
Japan’s newly-appointed Finance Minister Satsuki Katayama clarified on Thursday that she cannot stand by remarks she made earlier this year about the yen’s value against the U.S. dollar, citing her current responsibilities overseeing Japan’s currency and financial policy. Katayama’s Past Remarks on the Yen In March 2025, Katayama, a veteran upper house lawmaker, stated in
-

Core Scientific Shareholders Reject $9 Billion CoreWeave Acquisition, Deal Officially Terminated
Crypto mining firm Core Scientific (CORZ.O) has officially terminated its proposed $9 billion sale to CoreWeave (CRWV.O) after shareholders voted against the acquisition. This marks the second failed attempt by CoreWeave to acquire Core Scientific, following a previously rejected all-cash buyout offer in June 2024. Background on the CoreWeave Acquisition Attempt The $9 billion deal,
Recent Posts
- Real Madrid Top Earners Globally as Liverpool Surpasses Manchester United

- Andoni Iraola’s Future at Bournemouth Remains Uncertain Amid Transfer and Contract Questions

- “Over 5,000 Men Want to Marry Me” — Nkechi Blessing Cries Out Over DM Flood
- Fela’s Daughter Fires Back at Wizkid Amid Seun Kuti Feud
- Chioma Sparks Reactions With Humorous Response to Unwanted DMs


Hi, this is a comment. To get started with moderating, editing, and deleting comments, please visit the Comments screen in…